No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1594 |
4. Check minimum number of eventsNone |
1594 |
5. Include endpoints |
1692 |
6. Filter based on genotype QC (FinnGen only) |
1692 |
Control definitions (FinnGen only)
- Control exclude
- H7_LIDLACRIMALORBIT
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Disorders of orbit
based on the number of shared cases.
Similar with more cases:
- Disorders of eyelid, lacrimal system and orbit
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 11521 | 7147 | 4305 |
| Only index persons | 10492 | 6687 | 3805 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.17 | 0.20 | 0.12 |
| Only index persons | 0.21 | 0.25 | 0.15 |
| Median age at first event (years) | |||
| Whole population | 48.52 | 51.10 | 44.14 |
| Only index persons | 48.17 | 50.74 | 43.66 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1692 | 1195 | 497 |
| Unadjusted period prevalence (%) | 0.35 | 0.41 | 0.22 |
| Median age at first event (years) | 52.21 | 51.71 | 53.40 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1495
- Matched controls
- 14948
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
11751.9
323.0
677
*
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
86.2
323.0
729
163
H05.2
ICD-10 Finland
Exophthalmic conditions
+∞
323.0
322
*
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
38.2
323.0
439
161
H03BB01
ATC
carbimazole; oral
44.3
323.0
663
264
H06.2
ICD-10 Finland
Dysthyroid exophthalmos
2819.9
265.6
249
*
H03AA01
ATC
levothyroxine sodium; systemic
6.3
220.5
801
2327
H062, E050
ICD-10 Finland
NA
+∞
208.3
195
*
BAA60
NOMESCO Finland
Total thyroidectomy
24.1
198.1
289
147
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
4.9
178.8
950
3922
H05.0
ICD-10 Finland
Acute inflammation of orbit
+∞
176.6
166
*
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
27.5
146.9
205
86
104
Kela drug reimbursment
Thyroid insufficiency
7.7
137.4
353
579
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
186.8
131.9
136
8
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
80.6
130.2
146
20
H04.10
ICD-10 Finland
Dry eye syndrome
8.7
105.1
242
325
H53.2
ICD-10 Finland
Diplopia
14.6
102.9
179
138
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
37.0
100.3
129
38
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.1
88.4
413
1284
H05.1
ICD-10 Finland
Chronic inflammatory disorders of orbit
+∞
84.2
80
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.0
82.7
678
3216
E05
ICD-10 Finland
Thyrotoxicosis [hyperthyroidism]
29.6
81.1
110
40
H05.9
ICD-10 Finland
Disorder of orbit, unspecified
+∞
79.9
76
*
C07AA05
ATC
propranolol; systemic
3.4
77.6
469
1775
H50.2
ICD-10 Finland
Vertical strabismus
41.7
75.1
94
24
H02.3
ICD-10 Finland
Blepharochalasis
55.5
75.1
89
17
H02AB06
ATC
prednisolone; systemic
2.7
74.4
851
4869
XCK00
NOMESCO Finland
Perimetry
6.0
72.3
215
407
XCW99
NOMESCO Finland
Other investigative procedure of eye
4.5
71.7
287
755
H05.8
ICD-10 Finland
Other disorders of orbit
+∞
71.4
68
*
H02.4
ICD-10 Finland
Ptosis of eyelid
40.3
58.1
73
19
CA1AD
NOMESCO Finland
Orbita CT
200.9
56.4
58
*
CAC30
NOMESCO Finland
Decompression of orbit to sinuses
+∞
54.5
52
*
H00.03
ICD-10 Finland
Preseptal cellulite in the eyelid
461.2
45.5
45
*
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
67.2
45.4
52
8
A02BC02
ATC
pantoprazole; systemic
2.2
45.1
1019
7338
CAA30
NOMESCO Finland
Biopsy of orbit
439.9
43.4
43
*
ZXA10
NOMESCO Finland
Bilateral
2.6
38.6
322
1411
CAC44
NOMESCO Finland
Combined decompression of orbit
365.8
36.1
36
*
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.1
36.1
528
3045
CEC00
NOMESCO Finland
Recession of extraocular muscle
38.6
35.7
45
12
E06.2
ICD-10 Finland
Chronic thyroiditis with transient thyrotoxicosis
+∞
35.6
34
*
H57.1
ICD-10 Finland
Ocular pain
6.5
35.3
95
155
H02AB07
ATC
prednisone; oral
2.7
34.5
273
1154
H50.6
ICD-10 Finland
Mechanical strabismus
+∞
34.5
33
*
ZX120
NOMESCO Finland
Intravenous
3.1
34.5
209
746
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.0
33.7
145
395
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
5.5
33.2
102
197
H01.0
ICD-10 Finland
Blepharitis
4.8
31.9
111
246
XCK10
NOMESCO Finland
Photography of fundus of eye
3.0
31.4
196
711
3760A
ICD-9 Finland
Disorders of the orbit, Acute inflammation of orbit
+∞
31.4
30
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
31.0
442
2486
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
9.9
30.5
62
65
XCD10
NOMESCO Finland
Electrophysiological examination of eye
6.7
30.2
79
124
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
30.0
346
1766
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
30.8
29.5
39
13
H02.5
ICD-10 Finland
Other disorders affecting eyelid function
+∞
29.3
28
*
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
8.3
29.0
65
81
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
28.8
637
4218
CAC20
NOMESCO Finland
Lateral decompression of orbit
+∞
28.2
27
*
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
3.7
27.0
126
367
H50.0
ICD-10 Finland
Convergent concomitant strabismus
17.3
26.7
42
25
H02.0
ICD-10 Finland
Entropion and trichiasis of eyelid
142.6
26.7
28
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.1
26.4
159
559
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.5
26.4
229
1006
CBK00
NOMESCO Finland
Myotomy or resection of tarsal muscle or levator muscle of eyelid for correction of retraction
+∞
26.1
25
*
CAB00
NOMESCO Finland
Anterior orbitotomy with excision of lesion
+∞
26.1
25
*
CA1DG
NOMESCO Finland
Eye and orbita very extensive MRI examination with high intensity magnet
61.2
26.0
30
5
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
5.4
26.0
80
155
H50.8
ICD-10 Finland
Other specified strabismus
50.9
25.3
30
6
CBB10
NOMESCO Finland
Excision of redundant skin of eyelid
59.1
25.1
29
5
E03.89
ICD-10 Finland
Other specified hypothyroidism
4.3
25.0
97
240
T85
ICPC
Hyperthyroidism/thyrotoxicosis
17.4
24.9
39
23
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.7
24.8
185
745
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
91.6
24.7
27
*
CA1BD
NOMESCO Finland
Extensive orbita CT
132.2
24.7
26
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.2
24.4
77
154
E05.1
ICD-10 Finland
Thyrotoxicosis with toxic single thyroid nodule
42.1
23.7
29
7
WF099
NOMESCO Finland
Other radiotherapy
16.5
23.2
37
23
CEC10
NOMESCO Finland
Recession and resection of extraocular muscle
18.8
23.1
35
19
C07AB07
ATC
bisoprolol; oral
1.7
22.5
640
4487
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.9
22.4
143
524
WX002
NOMESCO Finland
Sedation and analgesia
2.0
20.9
301
1662
H05.5
ICD-10 Finland
Retained (old) foreign body following penetrating wound of orbit
+∞
20.9
20
*
CBB20
NOMESCO Finland
Correction of lax skin of eyelid and resection of herniated fat
212.8
20.6
21
*
CBB11
NOMESCO Finland
Resection of lax skin in upper eyelid
111.6
20.6
22
*
T86
ICPC
Hypothyroidism/myxoedema
3.7
20.4
93
266
XCC00
NOMESCO Finland
Investigative irrigation of lacrimal passages
27.5
20.1
27
10
2AB04
NOMESCO Finland
NA
23.7
20.0
28
12
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.0
19.1
115
405
E05.5
ICD-10 Finland
Thyroid crisis or storm
192.3
18.6
19
*
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
3.0
18.4
109
378
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.9
17.8
75
201
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
18.3
17.8
27
15
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
10.5
17.7
34
33
S01GX01
ATC
cromoglicic acid; ophthalmic
1.9
17.6
305
1790
AA1AD
NOMESCO Finland
CT of head and brain
1.9
17.3
309
1836
CS494
NOMESCO Finland
Other visual field testing
5.2
16.8
52
103
CEC60
NOMESCO Finland
Transposition of extraocular muscle with adjustable suture
64.1
16.8
19
*
H05.4
ICD-10 Finland
Enophthalmos
+∞
16.7
16
*
3763A
ICD-9 Finland
Disorders of the orbit, Other exophthalmic conditions
+∞
16.7
16
*
E03
ICD-10 Finland
Other hypothyroidism
2.8
16.6
110
412
CBB21
NOMESCO Finland
Correction of lax skin and resection of herniated fat in upper eyelid
91.1
16.6
18
*
CA1BM
NOMESCO Finland
Eye and orbita MRI examination with 3 Tesla magnet
91.1
16.6
18
*
CEW99
NOMESCO Finland
Other operation on extraocular muscle
40.5
16.3
20
5
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.9
16.3
100
358
N05CF01
ATC
zopiclone; oral
1.7
15.8
452
3091
H02.1
ICD-10 Finland
Ectropion of eyelid
60.7
15.8
18
*
CEC90
NOMESCO Finland
Total transposition of extraocular muscle or muscles
161.6
15.5
16
*
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
9.1
15.5
32
36
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
4.2
15.3
58
142
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
5.9
15.2
42
73
J01DB01
ATC
cefalexin; oral
1.7
15.0
1174
10279
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
14.8
326
2058
CE2W4
NOMESCO Finland
Eye movement mapping
32.0
14.8
19
6
UDM02
NOMESCO Finland
Sinoscopy
4.6
14.8
51
114
R51.80
ICD-10 Finland
Headache
1.9
14.7
218
1205
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
2.9
14.6
91
329
CAA00
NOMESCO Finland
Puncture of orbital abscess
+∞
14.6
14
*
TCC40
NOMESCO Finland
Closure of lacrimal canaliculus with plug
+∞
14.6
14
*
CB9S4
NOMESCO Finland
Photography of eyelids and eyebrows
80.9
14.6
16
*
F29
ICPC
Eye symptom/complaint other
2.4
14.3
122
528
N02BE01
ATC
paracetamol; systemic, rectal
1.7
14.2
1231
10968
Z90.0
ICD-10 Finland
Acquired absence of part of head and neck
42.9
14.1
17
*
WX402
NOMESCO Finland
General anaesthesia
1.8
14.0
249
1468
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
12.8
13.9
24
19
WX110
NOMESCO Finland
Local anesthesy
1.5
13.6
970
8173
3762A
ICD-9 Finland
Disorders of the orbit, Endocrine exophthalmos
+∞
13.6
13
*
ZXA00
NOMESCO Finland
Right side
1.7
13.5
369
2472
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.6
13.5
99
394
H02.8
ICD-10 Finland
Other specified disorders of eyelid
34.4
13.5
17
5
1XC02
NOMESCO Finland
NA
8.6
13.3
28
33
H50.1
ICD-10 Finland
Divergent concomitant strabismus
10.1
13.0
25
25
N02AX02
ATC
tramadol; systemic, rectal
1.5
13.0
556
4162
A11CC03
ATC
alfacalcidol; systemic
4.4
12.9
46
107
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
9.8
12.7
25
26
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
4.4
12.7
45
104
WX140
NOMESCO Finland
Parabulbar anesthesy
3.2
12.7
66
212
2420A
ICD-9 Finland
Thyrotoxicosis with or without goitre, Toxic diffuse goitre
32.3
12.6
16
5
H02AB09
ATC
hydrocortisone; systemic
4.0
12.5
49
125
ZXA05
NOMESCO Finland
Left side
1.6
12.5
338
2255
WF002
NOMESCO Finland
Radical radiotherapy
2.9
12.4
73
256
E05.89
ICD-10 Finland
Other thyrotoxicosis
14.5
12.3
20
14
S01ED01
ATC
timolol; ophthalmic
3.6
12.2
55
158
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.8
12.1
215
1263
A02BC01
ATC
omeprazole; systemic
1.6
12.0
372
2565
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
4.3
11.9
43
102
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
16.5
11.7
18
11
CD2S4
NOMESCO Finland
Photography of eye
16.5
11.7
18
11
H02.9
ICD-10 Finland
Disorder of eyelid, unspecified
30.3
11.6
15
5
H44.5
ICD-10 Finland
Degenerated conditions of globe
65.5
11.6
13
*
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
6.5
11.6
29
45
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
4.7
11.5
38
82
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
8.7
11.5
24
28
CAW99
NOMESCO Finland
Other operation on orbit
+∞
11.5
11
*
36907
ICD-8 Finland
Other inflammatory diseases of eye, Morbi inflammatori orbitae alii
+∞
11.5
11
*
36900
ICD-8 Finland
Other inflammatory diseases of eye, Abscessus orbitae
+∞
11.5
11
*
CBJ40
NOMESCO Finland
Resection of levator muscle of eyelid
+∞
11.5
11
*
A02BC05
ATC
esomeprazole; systemic
1.5
11.4
553
4222
E89.0
ICD-10 Finland
Postprocedural hypothyroidism
35.3
11.3
14
*
H10.4
ICD-10 Finland
Chronic conjunctivitis
12.8
11.1
19
15
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.5
11.1
757
6184
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.0
11.1
147
778
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
11.1
154
827
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.1
11.1
132
669
114
Kela drug reimbursment
Glaucoma
2.2
11.0
111
521
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
11.0
394
2807
106
Kela drug reimbursment
Hypoparathyroidism
12.0
10.8
19
16
N07BA03
ATC
varenicline; oral
2.6
10.8
79
315
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.2
10.7
116
562
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
8.0
10.6
23
29
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.0
10.5
61
212
CCD60
NOMESCO Finland
Transnasal dacryocystorhinostomy
110.8
10.4
11
*
H04.0
ICD-10 Finland
Dacryoadenitis
110.8
10.4
11
*
CBD99
NOMESCO Finland
Other plastic reconstruction of eyelid
+∞
10.4
10
*
CBH30
NOMESCO Finland
Tarsorraphy
+∞
10.4
10
*
H03BA02
ATC
propylthiouracil; oral
32.8
10.3
13
*
XCH00
NOMESCO Finland
Eye pressure measurement
2.8
10.3
64
231
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.1
10.3
120
602
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
10.2
304
2065
H04.3
ICD-10 Finland
Acute and unspecified inflammation of lacrimal passages
23.5
10.2
14
6
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
4.9
10.2
32
66
S18
ICPC
Laceration/cut
1.5
10.1
518
3979
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
6.5
10.0
25
39
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
10.0
362
2575
S01ED51
ATC
timolol, combinations; ophthalmic
2.3
10.0
95
437
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
4.1
10.0
37
91
XX3DW
NOMESCO Finland
Time consuming IT work
1.9
9.9
145
792
H00.1
ICD-10 Finland
Chalazion
4.3
9.8
35
83
S01EE01
ATC
latanoprost; ophthalmic
2.4
9.7
82
355
R4110
NOMESCO Finland
Physiotherapy
1.5
9.7
351
2495
TCC10
NOMESCO Finland
Probing of lacrimal canaliculus/duct
55.3
9.7
11
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
9.6
170
993
H40.0
ICD-10 Finland
Glaucoma suspect
2.1
9.6
104
506
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
2.3
9.6
87
391
CBN99
NOMESCO Finland
Other operation on eyelid for malposition
+∞
9.4
9
*
CA1CD
NOMESCO Finland
Very extensive orbita CT
+∞
9.4
9
*
CAE10
NOMESCO Finland
Revision and secondary implant in orbit
+∞
9.4
9
*
CBF10
NOMESCO Finland
Shortening of canthal ligaments and tarsal plate for ectropion
+∞
9.4
9
*
CBJ30
NOMESCO Finland
Plastic repair of levator aponeurosis of eyelid
+∞
9.4
9
*
S01KA02
ATC
hypromellose; ophthalmic
4.1
9.4
35
87
CBB00
NOMESCO Finland
Excision of chalazion
21.8
9.4
13
6
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
9.3
546
4287
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
9.6
9.3
18
19
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.5
9.3
314
2198
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
3.8
9.2
37
98
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.7
9.1
180
1091
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
9.0
199
1244
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
10.1
9.0
17
17
J31.0
ICD-10 Finland
Chronic rhinitis
2.0
8.9
106
538
A11CC02
ATC
dihydrotachysterol; oral
12.6
8.9
15
12
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
8.8
438
3322
H10.5
ICD-10 Finland
Blepharoconjunctivitis
4.6
8.8
29
64
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.0
8.7
106
543
E83.51
ICD-10 Finland
Hypocalcemia
8.3
8.6
18
22
N06AX11
ATC
mirtazapine; oral
1.5
8.6
415
3129
J32.1
ICD-10 Finland
Chronic frontal sinusitis
11.6
8.6
15
13
R01AD09
ATC
mometasone; nasal
1.4
8.6
610
4940
H01CB02
ATC
octreotide; parenteral
16.4
8.6
13
8
R03BB04
ATC
tiotropium bromide; inhalant
1.9
8.5
119
641
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
8.5
200
1272
J01.4
ICD-10 Finland
Acute pansinusitis
7.4
8.4
19
26
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.1
8.4
97
484
CBA10
NOMESCO Finland
Biopsy of eyelid
6.7
8.4
20
30
36902
ICD-8 Finland
Other inflammatory diseases of eye, Tenonitis
+∞
8.3
8
*
H05.3
ICD-10 Finland
Deformity of orbit
+∞
8.3
8
*
3761A
ICD-9 Finland
Disorders of the orbit, Chronic inflammatory disorders of orbit
+∞
8.3
8
*
CAB10
NOMESCO Finland
Lateral orbitotomy with excision of lesion
+∞
8.3
8
*
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.9
8.3
129
723
S01EC04
ATC
brinzolamide; ophthalmic
2.9
8.3
49
175
EBA00
NOMESCO Finland
Extraction of tooth
1.4
8.2
415
3155
R03AC02
ATC
salbutamol; inhalant
1.4
8.1
707
5910
H16.0
ICD-10 Finland
Corneal ulcer
2.6
8.1
59
236
N03AX16
ATC
pregabalin; oral
1.5
8.1
297
2107
H02AB04
ATC
methylprednisolone; systemic
1.6
8.0
194
1243
E05.80
ICD-10 Finland
Subacute thyrotoxicosis
5.9
8.0
21
36
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
7.9
644
5314
N03AX12
ATC
gabapentin; oral
1.6
7.8
189
1210
CS1H4
NOMESCO Finland
Retinal nerve fibre layer imaging
4.9
7.8
24
50
F01
ICPC
Eye pain
2.9
7.8
45
158
R74
ICPC
Upper respiratory infection acute
1.4
7.8
365
2730
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
7.7
603
4936
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
7.7
219
1465
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
7.6
458
3584
ZX050
NOMESCO Finland
Stereotactic radiotherapy
8.1
7.6
16
20
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
7.2
7.5
17
24
CBJ50
NOMESCO Finland
Operation for ptosis of eyebrow
80.5
7.4
8
*
CBG00
NOMESCO Finland
Epilation of cilia by electrolysis
80.5
7.4
8
*
CCA10
NOMESCO Finland
Biopsy of lacrimal gland
80.5
7.4
8
*
TCC30
NOMESCO Finland
Intubation of lacrimal canaliculus/duct
80.5
7.4
8
*
CFC00
NOMESCO Finland
Excision of lesion of conjunctiva
13.4
7.4
12
9
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
7.3
482
3824
M25.5
ICD-10 Finland
Pain in joint
1.4
7.3
362
2726
3112
FHL
Orbitotomy (includes biopsy and removal of local tumor or foreign object)
+∞
7.3
7
*
CCD50
NOMESCO Finland
Dacryocystorhinostomy with insertion of tube
+∞
7.3
7
*
CAE00
NOMESCO Finland
Removal of implant from orbit
+∞
7.3
7
*
CEA00
NOMESCO Finland
Biopsy of extraocular muscle
+∞
7.3
7
*
E50.0
ICD-10 Finland
Vitamin A deficiency with conjunctival xerosis
+∞
7.3
7
*
CBK99
NOMESCO Finland
Other operation for retraction of eyelid
+∞
7.3
7
*
J01FF01
ATC
clindamycin; systemic
1.4
7.3
345
2579
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
7.3
954
8452
R06AE07
ATC
cetirizine; oral
1.4
7.2
583
4783
S05.1
ICD-10 Finland
Contusion of eyeball and orbital tissues
4.7
7.2
23
50
H50.52
ICD-10 Finland
Exophoria
4.8
7.2
22
46
H02.2
ICD-10 Finland
Lagophthalmos
30.2
7.1
9
*
G44.2
ICD-10 Finland
Tension-type headache
1.6
7.1
173
1113
H53.8
ICD-10 Finland
Other visual disturbances
5.1
7.1
21
42
S01XA18
ATC
ciclosporin; ophthalmic
12.1
7.1
12
10
Z01.7
ICD-10 Finland
Laboratory examination
1.7
7.1
139
842
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
7.1
199
1328
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
8.8
7.0
14
16
H11.1
ICD-10 Finland
Conjunctival degenerations and deposits
7.0
7.0
16
23
H52.2
ICD-10 Finland
Astigmatism
4.0
7.0
26
66
ZX090
NOMESCO Finland
Other technic of radiotherapy
2.6
6.9
46
178
DPA30
NOMESCO Finland
Sphenotomy
5.5
6.9
19
35
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
5.5
6.9
19
35
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.6
6.8
167
1074
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
8.3
6.8
14
17
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.3
6.8
57
248
CS2P4
NOMESCO Finland
Optic nerve head imaging
9.4
6.8
13
14
M79.6
ICD-10 Finland
Pain in limb
1.4
6.8
440
3478
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
40.2
6.8
8
*
BAA50
NOMESCO Finland
Lobectomy and resection of contralateral lobe of thyroid gland
16.8
6.7
10
6
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.4
6.7
55
238
M54.5
ICD-10 Finland
Low back pain
1.4
6.7
405
3159
S01EE05
ATC
tafluprost; ophthalmic
2.7
6.7
44
169
A02BC03
ATC
lansoprazole; oral
1.4
6.7
373
2870
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
3.2
6.6
32
101
R53
ICD-10 Finland
Malaise and fatigue
1.5
6.6
246
1749
S01AA01
ATC
chloramphenicol; ophthalmic (antibiotics)
2.2
6.6
64
299
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
6.6
221
1534
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.5
6.6
236
1661
H11.4
ICD-10 Finland
Other conjunctival vascular disorders and cysts
8.7
6.6
13
15
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
6.5
309
2301
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
6.5
242
1716
H04.19
ICD-10 Finland
Other disorders of lacrimal gland
70.1
6.4
7
*
CDC00
NOMESCO Finland
Enucleation of eye
70.1
6.4
7
*
CA1DM
NOMESCO Finland
Eye and orbita very extensive MRI examination with 3 Tesla magnet
70.1
6.4
7
*
CFD10
NOMESCO Finland
Repair of conjunctiva
70.1
6.4
7
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
6.4
237
1683
C03CA01
ATC
furosemide; systemic
1.4
6.4
296
2198
J02AC01
ATC
fluconazole; systemic
1.3
6.4
554
4573
H40.9
ICD-10 Finland
Glaucoma, unspecified
3.8
6.4
25
67
N05BA01
ATC
diazepam; systemic, rectal
1.6
6.4
168
1101
BAA25
NOMESCO Finland
Bilateral partial excision of thyroid gland
9.3
6.3
12
13
R01AD12
ATC
fluticasone furoate; nasal
1.4
6.3
384
2995
H54.4
ICD-10 Finland
Blindness, monocular
18.1
6.3
9
5
K02.1
ICD-10 Finland
Caries of dentine
1.3
6.3
749
6473
CDC10
NOMESCO Finland
Enucleation of eye with insertion of prosthesis
+∞
6.3
6
*
3119
FHL
Other measure in this category
+∞
6.3
6
*
CBF99
NOMESCO Finland
Other operation for ectropion
+∞
6.3
6
*
CAB50
NOMESCO Finland
Orbitotomy with removal of foreign body
+∞
6.3
6
*
H01.80
ICD-10 Finland
Prolonged inflammation in the edge of the eyelid
26.8
6.2
8
*
Z97.0
ICD-10 Finland
Presence of artificial eye
26.8
6.2
8
*
H16.9
ICD-10 Finland
Keratitis, unspecified
4.1
6.2
22
54
S01GX09
ATC
olopatadine; ophthalmic
2.6
6.1
41
160
J01FA10
ATC
azithromycin; systemic
1.3
6.1
795
6943
H04.2
ICD-10 Finland
Epiphora
12.6
6.1
10
8
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.5
6.1
194
1332
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
2.8
6.1
36
131
H50.30
ICD-10 Finland
Intermittent esotropy
8.6
6.1
12
14
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
528
910
7.98
313.41
6.9
3.2
pmol/l
4.5
4.5
0.02
500
805
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
547
348
22.75
307.65
4.5
1.8
iu/l
5.6
4.7
0.73
354
123
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1450
11088
3.15
62.91
10.9
4.0
pmol/l
15.4
14.7
19.99
1372
10152
(3013650) Neutrophils [#/volume] in Blood by Automated count
1125
7992
2.22
50.67
10.6
8.7
e9/l
4.1
4.0
0.95
994
6983
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
266
1042
2.84
47.69
1.4
1.2
iu/ml
206.3
152.2
1.18
110
401
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
971
6610
2.10
47.54
7.9
6.5
mmol/l
1.2
1.2
1.47
835
5583
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
888
5983
2.02
43.13
6.8
5.8
mmol/l
1.2
1.2
1.28
831
5403
(3001604) Monocytes [#/volume] in Blood
968
6826
1.98
40.12
7.0
5.5
e9/l
0.6
0.6
2.37
843
5896
(3019198) Lymphocytes [#/volume] in Blood
988
7036
1.97
39.55
7.0
5.5
e9/l
1.9
1.9
0.35
882
6205
(3006315) Basophils [#/volume] in Blood
968
6852
1.96
39.37
7.0
5.5
e9/l
0.0
0.0
0.87
842
5925
(42870588) Differential panel, method unspecified - Blood
709
4521
1.98
39.17
6.8
5.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
992
7088
1.97
39.16
7.2
5.8
e9/l
0.2
0.2
1.54
875
6230
(3018418) pH of Serum or Plasma
632
3898
1.99
38.21
4.9
3.8
ph
7.4
7.4
2.09
118
725
(3002030) Lymphocytes/100 leukocytes in Blood
940
6638
1.94
37.94
7.1
5.7
%
28.0
28.6
0.95
883
6191
(3019069) Monocytes/100 leukocytes in Blood
915
6444
1.91
36.80
7.4
5.9
%
8.7
8.5
1.08
865
6040
(3006504) Eosinophils/100 leukocytes in Blood
910
6410
1.91
36.44
7.1
5.6
%
3.0
2.8
1.36
852
5973
(3018010) Neutrophils/100 leukocytes in Blood
924
6544
1.91
36.36
6.9
5.5
%
57.1
56.8
0.40
871
6129
(3024980) IgG subclass 4 [Mass/volume] in Serum
90
208
4.51
36.10
2.2
1.6
g/l
0.8
0.8
0.10
69
165
(3022096) Basophils/100 leukocytes in Blood
888
6219
1.90
36.06
7.1
5.7
%
0.7
0.7
0.26
835
5804
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1523
13040
2.68
33.90
11.9
4.8
mu/l
1.7
2.1
1.60
1445
11994
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1306
10556
2.04
32.69
9.3
7.2
u/l
77.8
78.1
0.08
1253
9894
(3015377) Calcium [Moles/volume] in Serum or Plasma
691
4601
1.85
31.60
3.6
3.3
mmol/l
2.3
2.4
2.59
611
4036
(3036481) Cortisol [Moles/volume] in Serum or Plasma
262
1276
2.25
28.73
2.5
2.0
nmol/l
352.6
371.9
0.91
241
1177
(40758558) Short blood count panel - Blood
548
3487
1.85
28.29
7.9
6.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
341
1879
2.02
26.99
1.4
1.3
titre
381.3
503.8
1.31
79
380
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
216
1006
2.31
26.22
3.6
3.8
ng/l
65.3
83.6
3.27
193
882
(3013826) Glucose [Moles/volume] in Serum or Plasma
1003
7783
1.71
24.64
4.9
4.5
mmol/l
6.5
6.6
1.24
939
7237
(3013707) Erythrocyte sedimentation rate by Westergren method
1247
10309
1.80
24.14
5.2
3.9
mm/h
12.7
11.8
1.39
1171
9537
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
791
5782
1.69
24.12
2.7
2.2
nmol/l
76.6
77.2
0.26
724
5201
(3024561) Albumin [Mass/volume] in Serum or Plasma
774
5683
1.67
22.77
4.9
4.6
g/l
35.6
35.8
0.41
727
5300
(4062490)
55
124
4.55
22.76
1.7
1.4
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
54
120
4.62
22.75
1.7
1.4
g/l
6.2
6.9
0.66
39
88
(3024139) IgG subclass 3 [Mass/volume] in Serum
54
120
4.62
22.75
1.7
1.4
g/l
0.3
0.4
0.38
40
88
(3028192) IgG subclass 2 [Mass/volume] in Serum
54
120
4.62
22.75
1.7
1.4
g/l
3.0
2.9
0.15
39
86
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
139
565
2.59
22.63
2.0
2.0
u/l
40.0
40.1
0.02
127
504
(3009445) Proteinase 3 Ab [Units/volume] in Serum
130
548
2.49
19.59
2.0
1.4
u/ml
14.5
9.6
—
6
10
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
97
355
2.84
19.36
1.9
2.1
mg/l
11.2
11.7
0.23
92
326
(3007853) Bacteria identified in Skin by Aerobe culture
263
1476
1.93
19.23
2.0
1.6
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
100
380
2.73
18.59
1.3
1.2
u/ml
94.1
33.8
—
7
20
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1547
14040
2.19
18.45
17.4
12.7
mg/l
22.1
22.5
0.15
1275
10952
(3021589) Normoblasts [#/volume] in Blood
798
6142
1.57
17.80
10.9
8.8
e9/l
0.0
0.0
0.11
650
4999
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
103
417
2.57
16.89
1.9
1.5
titre
1006.7
132.2
—
6
18
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
701
5293
1.55
16.69
2.1
1.9
pmol/l
96.6
96.1
0.10
346
2703
(3005719) IgG [Mass/volume] in Serum or Plasma
193
1024
2.00
16.51
3.5
2.6
g/l
10.2
10.4
0.33
179
936
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
80
293
2.82
15.96
1.2
1.2
u/ml
61.0
48.6
—
8
30
(3017143) Hepatitis C virus Ab [Presence] in Serum
261
1556
1.80
15.58
1.5
1.6
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
34
71
4.87
15.46
1.1
1.1
nmol/l
1.5
0.9
—
8
12
(3007164) IgA [Mass/volume] in Serum or Plasma
405
2729
1.64
15.43
1.6
1.4
g/l
2.4
2.3
0.14
240
1691
(3030467) Casts [#/volume] in Urine by Automated count
503
3576
1.58
15.32
3.2
2.9
e6/l
0.3
0.4
1.77
366
2648
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
361
2385
1.65
14.80
3.2
2.9
mmol/l
2.4
2.4
0.29
311
2093
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
50
145
3.52
14.75
3.2
4.4
u/ml
41.3
81.2
0.70
12
42
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
874
7043
1.50
14.66
6.5
6.1
umol/l
10.6
11.1
1.07
834
6685
(3031040) Bacteria [#/volume] in Urine by Automated count
1071
9028
1.51
14.21
4.8
4.2
e6/l
34.2
2200.0
—
6
128
(3023103) Potassium [Moles/volume] in Serum or Plasma
1557
14392
2.03
14.08
19.5
14.6
mmol/l
3.9
4.0
3.16
1529
13982
(3019550) Sodium [Moles/volume] in Serum or Plasma
1552
14347
1.99
13.76
19.3
14.5
mmol/l
139.7
139.7
0.01
1528
13961
(36304419) Bacteria [Presence] in Urine
487
3512
1.54
13.64
3.3
2.9
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
96
416
2.39
13.63
1.9
1.9
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
615
4662
1.50
13.61
3.6
3.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
285
1824
1.68
13.07
2.2
2.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
315
2081
1.63
12.74
3.8
3.4
mmol/l
0.8
0.8
0.70
292
1951
(3018095) Leukocytes [#/volume] in Urine
607
4647
1.48
12.54
4.1
3.5
e6/l
80.1
110.8
0.66
409
3187
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
82
345
2.45
12.44
1.3
1.2
u/ml
12.9
2.3
—
5
34
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
83
352
2.43
12.38
1.3
1.2
u/ml
16.9
10.1
—
8
58
(3033658) Prothrombin time (PT) actual/Normal
464
3375
1.52
12.27
4.6
3.7
%
92.5
93.3
0.26
455
3286
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
316
2114
1.61
12.09
1.5
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
364
2525
1.56
11.91
1.8
1.9
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
528
3964
1.48
11.90
2.4
2.0
u/l
158.2
225.3
1.37
480
3731
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
89
399
2.30
11.73
1.7
1.6
iu/ml
0.3
0.2
0.17
16
79
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1404
12738
1.60
11.70
6.2
5.4
mmol/mol
39.4
39.4
0.01
1318
11809
(3026782) Osmolality of Urine
360
2503
1.56
11.63
3.1
2.6
mosm/kgh2o
542.6
543.2
0.02
300
2132
(3035637) Corticotropin [Mass/volume] in Plasma
45
143
3.21
11.56
2.0
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1096
9474
1.45
11.37
5.1
4.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
223
1385
1.70
11.36
4.6
4.4
u/l
232.4
251.3
0.90
213
1304
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
350
2431
1.55
11.33
4.2
3.5
ng/l
343.9
456.2
0.32
269
1775
(3002582) Erythrocytes [#/volume] in Urine
519
3918
1.47
11.25
3.4
3.0
e6/l
34.1
55.3
1.10
382
2954
(3028026) IgM [Mass/volume] in Serum or Plasma
147
809
1.89
11.23
1.8
1.7
g/l
1.2
1.4
1.37
134
741
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1085
9381
1.44
11.10
3.5
3.0
u/l
44.9
45.7
0.11
1027
8772
(40768804) Tissue Pathology biopsy report
707
5667
1.43
11.06
2.2
2.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
446
3286
1.49
10.87
2.5
2.1
mg/l
2.7
3.0
1.70
401
2777
(3021879) Hepatitis B virus core Ab [Presence] in Serum
174
1023
1.78
10.75
1.4
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
638
5044
1.43
10.67
9.4
8.2
inr
1.2
1.2
0.11
177
1453
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
297
2013
1.58
10.65
2.1
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
591
4615
1.43
10.56
3.4
3.2
u/l
29.6
32.4
1.18
554
4390
(3003458) Phosphate [Moles/volume] in Serum or Plasma
255
1673
1.62
10.47
5.7
5.5
mmol/l
1.0
1.0
0.07
233
1540
(3023368) Bacteria identified in Blood by Culture
451
3355
1.47
10.40
4.7
4.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
60
238
2.58
10.34
2.1
2.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
373
2674
1.51
10.33
2.7
2.4
e6/l
6.6
6.8
0.06
314
2345
(36660697) Celiac disease serology panel - Serum
186
1129
1.73
10.28
1.2
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
85
404
2.16
9.76
1.7
1.6
g/l
0.2
0.2
0.18
77
383
(3004588) Protein electrophoresis panel - Serum or Plasma
147
846
1.81
9.75
2.5
2.5
—
—
—
0
0
(3044889) 12 lead EKG panel
1103
9673
1.40
9.65
3.9
3.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
537
4187
1.41
9.45
2.7
2.5
u/l
56.9
56.8
0.02
502
3874
(3001122) Ferritin [Mass/volume] in Serum or Plasma
744
6134
1.38
9.37
3.4
2.7
ug/l
129.6
113.4
0.59
696
5686
(3039162) Centromere protein B Ab [Units/volume] in Serum
46
168
2.79
9.33
1.1
1.3
—
59.2
—
0
9
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
86
419
2.11
9.28
1.6
1.6
g/l
1.2
1.2
0.00
78
396
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1462
13559
1.58
9.25
5.0
4.3
mmol/l
5.9
5.9
0.11
1361
12382
(3052851) Hemolysis interference index of Serum or Plasma
80
380
2.16
9.22
2.6
3.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
168
1025
1.71
9.10
2.5
2.8
g/l
66.7
66.8
0.06
156
933
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
77
363
2.17
9.04
2.9
2.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
421
3163
1.44
9.04
1.4
1.2
u/ml
1.3
1.7
0.40
111
838
(3002385) Erythrocyte distribution width [Ratio]
1301
11802
1.44
8.99
22.8
15.7
%
13.7
13.6
0.33
1283
11534
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
344
2489
1.48
8.98
1.3
1.3
iu/ml
24.4
35.1
1.36
97
802
(3015171) Extractable nuclear Ab [Units/volume] in Serum
100
523
1.97
8.91
1.3
1.2
u/ml
0.2
1.4
—
10
45
(3044640) Blood type and Crossmatch panel - Blood
552
4372
1.39
8.71
2.6
2.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
287
2023
1.50
8.48
3.0
2.8
e6/l
3.6
3.2
0.16
147
1066
(3021601) Nitrite [Presence] in Urine by Test strip
800
6749
1.35
8.39
5.3
4.8
estimate
0.0
0.0
0.50
164
1238
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
29
88
3.34
8.08
1.6
1.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1577
14990
1.77
8.03
13.9
9.8
u/l
25.4
25.8
0.47
1542
14477
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
301
2165
1.47
8.02
2.8
2.6
e6/l
1.3
1.2
0.14
161
1197
(3009261) Glucose [Presence] in Urine by Test strip
804
6819
1.34
8.00
3.8
3.5
estimate
0.0
0.0
0.25
159
1201
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
88
462
1.95
7.79
2.9
2.6
g/l
3.1
3.1
0.25
74
362
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1424
13244
1.47
7.71
15.9
11.7
ml/min/173m2
84.0
82.8
1.26
1219
10865
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
74
368
2.06
7.62
3.0
2.5
g/l
0.0
0.0
0.50
68
344
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
323
2384
1.44
7.49
1.3
1.2
u/ml
10.2
12.1
0.19
104
962
(3005322) IgE [Units/volume] in Serum or Plasma
149
928
1.66
7.48
1.6
1.2
u/ml
317.3
204.9
0.72
144
849
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
75
379
2.02
7.40
2.9
2.4
g/l
38.4
38.0
0.27
68
332
(3035350) Ketones [Presence] in Urine by Test strip
790
6735
1.32
7.36
3.8
3.5
estimate
0.0
0.0
0.00
158
1217
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
428
3328
1.38
7.34
2.6
2.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
386
2954
1.40
7.27
1.5
1.5
nmol/l
19.8
21.0
0.93
329
2505
(3018677) aPTT in Platelet poor plasma by Coagulation assay
267
1912
1.47
7.24
2.6
2.2
s
30.0
29.5
0.49
251
1850
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
69
342
2.06
7.18
3.1
2.6
g/l
0.0
0.0
0.00
63
320
(3001019) Free T4 and TSH panel - Serum or Plasma
136
837
1.68
7.15
2.0
1.7
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
84
451
1.91
6.98
2.9
2.6
g/l
10.2
10.1
0.07
74
389
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
68
339
2.05
6.98
3.1
2.6
g/l
0.0
0.0
0.00
63
319
(3000494) Fungus identified in Specimen by Culture
224
1564
1.50
6.87
1.8
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
89
491
1.86
6.82
2.9
2.5
g/l
4.2
3.8
0.58
73
353
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
92
513
1.84
6.81
1.9
1.9
g/l
1.6
1.5
0.12
77
447
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
203
1391
1.52
6.81
1.9
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
401
3119
1.37
6.80
5.3
4.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
400
3110
1.37
6.80
3.6
3.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
89
492
1.85
6.77
2.9
2.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
89
492
1.85
6.77
2.9
2.5
g/l
7.7
7.4
0.62
74
373
(3000492) Spirometry study
198
1353
1.52
6.73
1.5
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
201
1382
1.52
6.64
1.9
1.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
254
1833
1.45
6.59
2.6
2.3
g/l
2.4
2.4
0.28
233
1701
(3027945) Reticulocytes/100 erythrocytes in Blood
198
1360
1.52
6.57
2.7
2.6
%
1.7
1.8
1.56
186
1212
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
78
418
1.91
6.54
2.9
2.6
g/l
0.7
1.0
0.24
70
374
(3003396) Base excess in Arterial blood by calculation
202
1398
1.51
6.46
6.9
7.9
mmol/l
1.4
1.1
0.44
159
1100
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
135
853
1.63
6.43
1.3
1.3
au/ml
37.5
46.7
—
5
44
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
109
651
1.72
6.42
7.6
10.1
mmol/l
25.0
24.4
1.15
102
610
(3019309) Folate [Moles/volume] in Red Blood Cells
307
2305
1.41
6.40
1.8
1.7
nmol/l
1103.0
1215.9
1.53
231
1731
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
53
249
2.17
6.36
1.5
1.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
48
217
2.25
6.33
1.4
1.3
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
202
1405
1.50
6.31
6.9
7.8
kpa
12.4
12.6
0.28
188
1345
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
202
1405
1.50
6.31
6.9
7.8
kpa
5.2
5.1
0.68
189
1344
(40768795) Lymph node Pathology biopsy report
35
137
2.59
6.30
1.2
1.2
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
14
30
4.70
6.21
1.5
1.4
ug/l
0.4
0.4
—
6
20
(3009508) Creatinine [Moles/volume] in Urine
502
4103
1.32
6.01
3.2
3.2
mmol/l
7.4
7.4
0.10
423
3460
(4035726)
177
1213
1.51
5.94
1.5
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
145
952
1.57
5.90
2.4
3.0
ng/l
184.6
167.2
0.21
125
873
(3023520) Reticulocytes [#/volume] in Blood
152
1010
1.55
5.87
2.9
2.6
e9/l
70.8
70.4
0.05
107
763
(3017732) Neutrophils [#/volume] in Blood
145
954
1.57
5.85
3.1
2.7
e9/l
4.2
4.0
0.42
120
759
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
50
238
2.13
5.84
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
50
238
2.13
5.84
1.4
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
502
4117
1.31
5.83
3.4
3.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
70
379
1.88
5.73
1.2
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
36
151
2.41
5.65
2.4
3.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
581
4883
1.29
5.56
3.3
3.3
ng/l
31.8
41.0
0.47
345
3155
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
214
1544
1.44
5.54
2.5
2.6
umol/l
5.5
8.0
3.97
184
1334
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
24
83
2.92
5.47
1.7
1.3
u/l
5.4
6.9
0.79
18
72
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
752
6538
1.27
5.45
4.1
3.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
116
737
1.62
5.43
1.7
1.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
229
1690
1.41
5.23
2.8
2.4
%
21.3
23.1
1.13
192
1450
(3022948) Iron [Moles/volume] in Serum or Plasma
266
2015
1.38
5.21
2.7
2.4
umol/l
13.0
13.5
0.49
245
1859
(40761511) CBC panel - Blood by Automated count
1535
14693
1.48
5.21
17.0
12.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
131
869
1.55
5.12
1.7
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
231
1714
1.40
5.12
2.1
2.2
ug/g
177.5
113.7
0.79
188
1365
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
175
1234
1.47
5.11
2.4
2.3
u/l
30.5
40.3
1.55
145
1053
(3026389) Candida sp identified in Specimen by Organism specific culture
37
165
2.27
5.09
1.2
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
31
130
2.41
4.90
1.2
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
31
130
2.41
4.90
2.5
2.0
e9/l
1.5
1.2
0.97
14
78
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1019
9251
1.26
4.87
3.1
3.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
50
256
1.98
4.86
1.3
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
24
89
2.72
4.85
5.5
6.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
28
113
2.50
4.80
1.6
1.3
u/ml
0.8
0.6
0.15
18
50
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
25
96
2.63
4.73
3.1
1.9
e6/l
759.3
700.2
0.19
14
41
(3002032) Base excess in Venous blood by calculation
160
1128
1.46
4.69
3.5
3.6
mmol/l
2.5
1.8
1.68
111
905
(3002256) Pathology report gross observation
231
1740
1.38
4.67
1.2
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
82
499
1.68
4.58
1.1
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1618
15717
1.67
4.56
27.9
18.9
e9/l
259.1
256.4
0.92
1582
15310
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
92
579
1.62
4.52
3.8
4.0
mmol/l
25.0
24.1
2.05
87
521
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
23
87
2.67
4.49
1.1
1.1
u/l
1.0
1.1
—
9
46
(3024731) MCV [Entitic volume]
1618
15724
1.66
4.46
27.8
18.8
fl
91.0
90.8
0.61
1604
15502
(3035941) MCH [Entitic mass]
1618
15726
1.66
4.43
27.7
18.8
pg
30.2
30.2
0.05
1604
15501
(3026361) Erythrocytes [#/volume] in Blood
1618
15727
1.66
4.42
27.9
18.9
e12/l
4.5
4.5
0.08
1577
15273
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
133
916
1.49
4.39
2.0
1.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
30
131
2.31
4.37
1.5
1.7
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1618
15731
1.65
4.36
27.9
18.9
e9/l
6.8
6.7
1.33
1578
15274
(3000963) Hemoglobin [Mass/volume] in Blood
1618
15734
1.65
4.32
28.0
19.0
g/l
134.6
134.8
0.22
1605
15507
(3044290) Cell count panel - Cerebral spinal fluid
50
268
1.89
4.29
1.5
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
452
3784
1.27
4.27
3.4
3.3
mg/l
456.7
382.7
0.12
286
2335
(3000991) Gas panel - Venous blood
146
1031
1.46
4.26
7.6
8.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
325
2612
1.30
4.24
1.5
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
32
147
2.20
4.16
2.1
1.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
61
352
1.76
4.15
1.3
1.3
u/l
13.8
10.9
0.61
45
284
(3037756) Immunofixation for Serum or Plasma
51
279
1.85
4.13
1.3
1.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
241
1865
1.34
4.10
1.2
1.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
25
104
2.42
4.06
1.3
1.1
titre
65.0
157.4
—
6
19
(3028433) Virus identified in Specimen by Culture
14
42
3.35
4.04
1.0
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
14
42
3.35
4.04
3.1
2.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
439
3684
1.26
4.03
1.6
1.6
mmol/l
1.3
1.4
0.36
369
3112
(3000093) Morphology [Interpretation] in Blood Narrative
26
111
2.36
4.00
1.2
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
202
1528
1.37
3.99
1.3
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
22
87
2.55
3.97
1.2
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
203
1539
1.36
3.95
21.6
21.4
inr
1.2
1.3
0.35
28
216
(3025159) Blasts/100 leukocytes in Blood
143
1021
1.44
3.95
3.8
4.1
%
0.0
0.8
0.92
41
238
(3034860) Kappa light chains.free [Mass/volume] in Serum
63
373
1.72
3.94
3.9
3.7
mg/l
37.5
74.7
1.15
47
307
(3021447) Carbon dioxide [Partial pressure] in Venous blood
156
1133
1.42
3.92
3.5
3.6
kpa
5.7
5.8
0.57
142
1094
(40759836) Histone Ab [Presence] in Serum by Immunoblot
25
106
2.38
3.91
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
25
106
2.38
3.91
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
25
106
2.38
3.91
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
25
107
2.36
3.84
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
25
107
2.36
3.84
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
25
107
2.36
3.84
1.1
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
150
1087
1.42
3.83
4.1
4.0
%
0.0
0.1
1.66
47
277
(3003327) Ova and parasites identified in Stool by Light microscopy
71
440
1.64
3.76
1.5
1.7
—
—
—
0
0
(4010399)
131
930
1.44
3.74
1.7
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
101
681
1.51
3.73
2.4
2.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
156
1144
1.40
3.72
4.0
4.0
%
1.0
1.0
0.01
51
307
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
46
253
1.84
3.69
5.9
5.4
iu/ml
254.0
298.8
—
6
38
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
26
116
2.26
3.65
2.9
3.5
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
62
374
1.68
3.64
3.9
3.6
mg/l
57.1
43.8
0.21
47
309
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
148
1081
1.40
3.62
3.5
3.4
mmol/l
1.2
1.2
0.32
134
931
(3004616) Nuclear Ab [Presence] in Serum
30
143
2.12
3.60
1.4
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
109
757
1.47
3.50
1.3
1.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
13
41
3.19
3.49
2.8
2.4
ug/l
1.0
1.1
0.13
13
36
(3002179) Metamyelocytes/100 leukocytes in Blood
142
1037
1.40
3.48
4.1
3.9
%
0.6
0.6
0.16
39
221
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
414
3503
1.24
3.48
2.7
3.0
ng/l
1116.7
1114.0
0.01
348
2923
(3020779) Urea [Moles/volume] in Serum or Plasma
143
1046
1.40
3.48
7.7
7.7
mmol/l
8.8
9.1
0.23
134
994
(3023323) Follitropin [Units/volume] in Serum or Plasma
102
703
1.48
3.41
1.4
1.4
iu/l
28.9
30.8
0.24
81
602
(3016502) Oxygen saturation in Arterial blood
164
1232
1.37
3.40
7.7
8.4
%
95.9
95.8
0.05
155
1189
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
9
18
5.02
3.37
1.0
2.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
465
3998
1.22
3.35
4.1
3.9
mg/mmol
8.1
8.1
0.00
287
2465
(3014111) Lactate [Moles/volume] in Serum or Plasma
146
1081
1.38
3.31
6.4
7.3
mmol/l
1.2
1.4
1.27
137
1035
(3047181) Lactate [Moles/volume] in Blood
61
378
1.64
3.27
6.0
7.5
mmol/l
1.4
1.2
0.56
54
325
(3023419) Bacteria identified in Sputum by Culture
30
149
2.03
3.26
1.9
3.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
60
371
1.64
3.24
1.2
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
58
356
1.65
3.23
1.8
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
48
280
1.74
3.21
3.4
3.4
%
56.8
57.9
0.22
48
280
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
26
123
2.13
3.20
1.5
1.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
13
44
2.97
3.13
3.1
5.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
27
131
2.08
3.13
1.1
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
101
709
1.45
3.10
1.9
1.7
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
8
16
5.02
3.05
1.5
4.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
7
12
5.85
3.02
1.1
1.2
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
24
113
2.14
3.01
2.1
1.9
%
37.4
42.6
—
7
15
(3029075) Extractable nuclear Ab panel - Serum
12
40
3.01
2.97
1.0
1.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
61
388
1.59
2.97
1.3
1.4
ug/g
259.1
299.7
0.78
35
214
(40761536) Microorganisms panel - Urine sediment
153
1163
1.35
2.97
5.1
3.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
49
296
1.67
2.92
1.8
1.6
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
13
46
2.84
2.92
1.0
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
93
652
1.45
2.90
9.9
11.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
77
520
1.50
2.89
1.7
1.7
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
9
6.68
2.87
1.5
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
43
253
1.72
2.83
1.8
3.1
umol/l
31.7
33.9
0.33
38
215
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
13
47
2.78
2.82
1.0
1.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
401
3453
1.21
2.79
2.7
2.5
umol/l
3462.6
5382.9
0.48
360
3005
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
26
131
2.00
2.76
2.3
1.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
12
42
2.87
2.75
1.2
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
46
279
1.67
2.72
3.4
3.8
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
21
98
2.16
2.71
1.2
1.1
mg/l
320.8
248.4
0.55
16
81
(3003338) MCHC [Mass/volume]
1271
12111
1.20
2.66
24.2
16.4
g/l
331.7
332.1
0.86
1259
12017
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
48
297
1.63
2.64
1.5
1.6
e6/l
1289.5
1764.2
0.14
39
240
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
48
297
1.63
2.64
1.5
1.5
e6/l
50.5
14.8
0.90
38
229
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
102
741
1.40
2.64
1.0
1.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1359
13034
1.22
2.64
20.8
13.8
%
39.8
39.7
0.17
1040
9597
(3002173) Hemoglobin [Mass/volume] in Arterial blood
150
1159
1.32
2.63
8.2
8.7
g/l
122.9
120.8
0.63
144
1116
(3017446) Testosterone [Moles/volume] in Serum or Plasma
98
708
1.41
2.62
2.6
2.2
nmol/l
10.8
12.4
1.01
89
627
(4198724)
14
55
2.56
2.61
1.3
1.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
362
3106
1.21
2.61
2.0
1.8
mg/l
1.2
1.1
0.06
267
2338
(3023410) Appearance of Cerebral spinal fluid
27
141
1.93
2.61
1.4
2.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
7
15
4.68
2.60
2.0
1.7
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
60
394
1.54
2.59
1.1
1.1
u/ml
2.3
6.3
—
6
51
(3025130) Human papilloma virus identified in Specimen
36
207
1.76
2.59
1.7
1.8
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
72
493
1.48
2.56
1.7
1.6
mu/l
294.4
295.4
0.02
67
447
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
11
5.47
2.54
1.2
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
15
62
2.43
2.54
2.9
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
15
62
2.43
2.54
2.9
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
15
62
2.43
2.54
2.9
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
15
62
2.43
2.54
2.9
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
76
529
1.46
2.49
2.4
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
22
109
2.03
2.46
2.5
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
22
109
2.03
2.46
2.5
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
22
109
2.03
2.46
2.5
1.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
15
63
2.39
2.46
1.7
2.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
19
89
2.15
2.45
3.2
2.8
nmol/l
68.3
96.3
1.20
19
89
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
47
296
1.60
2.43
2.0
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
31
174
1.80
2.43
1.1
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
37
219
1.70
2.42
1.5
2.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
10
34
2.95
2.41
1.0
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
195
1584
1.26
2.35
1.7
1.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
166
1322
1.28
2.35
3.5
3.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1458
14123
1.23
2.34
5.1
4.7
mmol/l
2.8
2.8
0.15
1350
13024
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
21
105
2.01
2.31
1.3
1.2
mg/l
39.9
38.6
0.06
14
86
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
9
28
3.23
2.30
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
9
28
3.23
2.30
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
9
28
3.23
2.30
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
9
28
3.23
2.30
1.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
69
480
1.46
2.29
2.0
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
52
341
1.54
2.29
1.2
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
68
472
1.46
2.29
1.2
1.3
miu/ml
180.9
226.0
0.44
29
225
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
6
13
4.63
2.27
1.2
1.2
u/l
47.7
14.0
—
6
13
(3004809) Band form neutrophils/100 leukocytes in Blood
32
187
1.72
2.21
4.6
3.2
%
0.9
1.2
0.63
27
153
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
20
100
2.01
2.21
1.2
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
40
249
1.62
2.20
2.3
2.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
15
67
2.25
2.18
2.5
1.9
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
15
67
2.25
2.18
2.5
1.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
167
1347
1.27
2.15
1.6
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
58
396
1.48
2.14
1.1
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
155
1240
1.28
2.13
2.4
2.2
g/l
0.2
0.2
0.17
142
1165
(3019225) pH of Specimen
166
1341
1.26
2.11
6.3
4.0
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
20
102
1.97
2.10
1.8
1.9
%
10.6
13.8
—
9
51
(3014765) Yersinia sp identified in Stool by Organism specific culture
58
398
1.47
2.09
1.1
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
105
800
1.33
2.07
5.3
5.2
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
5
10
5.01
2.07
2.0
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
44
285
1.56
2.07
1.4
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
52
350
1.50
2.06
2.0
1.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
53
360
1.49
2.02
1.2
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
8
26
3.09
2.01
1.3
1.0
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
17
83
2.06
2.01
3.4
2.3
%
58.2
40.7
—
6
30
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
174
1423
1.25
2.00
2.1
1.9
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
13
57
2.29
1.98
1.2
1.1
miu/ml
1695.2
1796.7
0.10
13
57
(3048929) Epstein Barr virus Ab [Presence] in Serum
62
437
1.43
1.96
1.3
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
20
105
1.92
1.96
1.3
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
18
91
1.99
1.95
1.7
1.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
12
51
2.36
1.95
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
58
405
1.45
1.93
1.1
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
43
283
1.53
1.91
1.5
1.4
—
—
—
0
0
(3039000) Anion gap in Blood
41
267
1.55
1.90
7.3
9.0
mmol/l
11.2
11.3
0.09
35
236
(3014148) Varicella zoster virus Ab [Titer] in Serum
27
158
1.72
1.89
1.1
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
54
374
1.46
1.88
1.4
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
44
292
1.52
1.88
2.1
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
14
65
2.16
1.88
1.8
1.8
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
37
236
1.58
1.88
1.1
1.1
u/ml
1.2
2.6
0.51
13
63
(3018572) Chloride [Moles/volume] in Blood
41
268
1.54
1.88
7.3
8.9
mmol/l
105.6
105.2
0.27
35
237
(3026250) Tacrolimus [Mass/volume] in Blood
12
52
2.32
1.88
45.3
29.9
ug/l
5.9
7.3
1.72
12
47
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
8
28
2.87
1.86
1.3
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
19
100
1.91
1.85
2.7
2.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
40
261
1.55
1.85
1.4
1.4
u/ml
223.5
111.0
0.47
11
44
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
17
86
1.99
1.85
1.2
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
309
2697
1.18
1.83
1.4
1.4
—
—
—
0
0
(3013512) EKG study
427
3823
1.16
1.83
3.7
3.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
12
53
2.27
1.80
3.0
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
12
53
2.27
1.80
3.0
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
73
2.06
1.80
1.1
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
33
207
1.61
1.80
1.1
1.0
u/ml
2.0
2.7
0.33
11
88
(3044941) Cell count panel - Synovial fluid
34
215
1.59
1.80
2.1
1.5
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
7
23
3.05
1.80
1.3
1.0
mg/g
10.1
6.2
—
7
23
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
130
1042
1.27
1.80
2.2
2.3
ug/l
6.1
7.6
0.71
107
930
(4015189)
8
29
2.77
1.79
2.1
2.6
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
27
161
1.69
1.78
2.1
2.2
umol/l
4.4
5.0
0.25
18
116
(3045142) Bone marrow Pathology biopsy report
27
161
1.69
1.78
1.2
1.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
59
422
1.41
1.75
2.6
2.1
ug/l
147.6
401.4
1.53
54
391
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
18
95
1.90
1.75
1.9
2.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
12
54
2.23
1.74
3.0
1.7
—
—
—
0
0
(3036489) Thrombin time
71
526
1.37
1.72
2.7
2.2
s
21.4
21.1
0.25
65
467
(3003888) Timothy IgE Ab [Units/volume] in Serum
39
258
1.52
1.71
1.0
1.1
u/ml
1.6
5.1
3.14
25
138
(3016879) Cocaine [Presence] in Urine
65
478
1.37
1.66
1.6
1.9
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
15
76
1.98
1.64
3.7
3.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
188
1589
1.21
1.61
2.2
2.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
72
542
1.34
1.60
1.2
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
20
3.01
1.58
1.7
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
68
509
1.35
1.57
1.6
1.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
398
3586
1.14
1.55
4.4
3.8
estimate
0.0
0.0
1.08
166
1214
(3006462) Nitrate [Presence] in Urine
12
57
2.11
1.55
1.7
3.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
28
176
1.60
1.55
1.0
1.1
u/ml
2.1
4.3
0.69
14
72
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1427
13904
1.17
1.55
4.5
4.3
mmol/l
4.8
4.8
0.16
1330
12922
(4027681)
16
85
1.89
1.55
1.6
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
52
374
1.40
1.53
3.6
3.6
u/ml
0.4
0.4
0.20
21
200
(1001926) Buprenorphine [Presence] in Urine by Screen method
55
400
1.39
1.52
1.7
1.7
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
15
3.34
1.52
1.2
1.3
ng/l
32.4
89.9
—
5
15
(3041096) Erythrocytes [Presence] in Urine by Automated
412
3727
1.14
1.51
3.7
3.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
37
250
1.49
1.51
1.7
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
68
513
1.34
1.50
1.6
1.8
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
21
2.86
1.50
1.5
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
11
51
2.16
1.50
1.0
1.0
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
15
79
1.91
1.49
1.3
1.5
umol/l
39.2
27.0
0.52
15
74
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
12
58
2.08
1.49
1.0
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
20
116
1.73
1.49
5.8
3.1
%
63.5
55.2
1.07
15
83
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
171
1446
1.20
1.48
1.3
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
21
124
1.70
1.47
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
113
917
1.25
1.45
1.2
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
7
28
2.51
1.45
2.1
2.0
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
14
73
1.93
1.44
1.1
1.2
—
14.6
—
0
9
(4094501)
50
362
1.39
1.43
1.1
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
9
39
2.31
1.43
1.3
1.3
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
42
295
1.43
1.42
2.0
1.7
nmol/l
41.1
40.7
0.03
42
285
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
567
5251
1.12
1.41
4.2
3.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
68
519
1.32
1.41
1.6
1.8
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
44
313
1.42
1.40
2.1
1.7
e6/l
7865.5
13381.1
0.92
37
233
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
191
1641
1.18
1.39
1.7
1.8
%
1.4
1.4
0.24
165
1456
(3024354) Oxygen [Partial pressure] in Venous blood
114
931
1.24
1.39
3.1
3.0
kpa
4.8
4.6
0.96
106
898
(3028300) Cannabinoids [Presence] in Urine
68
520
1.32
1.39
1.6
1.8
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
29
2.42
1.39
1.3
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
19
111
1.72
1.39
2.8
2.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
430
3923
1.13
1.38
1.5
1.5
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
34
231
1.48
1.37
1.2
1.2
u/ml
2.7
5.8
1.21
25
91
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
34
231
1.48
1.37
1.2
1.2
u/ml
2.7
2.8
0.02
15
68
(3037692) Legionella sp identified in Specimen by Organism specific culture
9
41
2.20
1.37
1.9
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
6
23
2.61
1.37
4.0
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
6
23
2.61
1.37
1.5
1.4
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
17
2.95
1.36
1.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
9
42
2.15
1.33
1.1
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
36
249
1.46
1.33
1.0
1.1
u/ml
0.7
1.7
0.77
22
113
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
216
1.49
1.33
1.5
1.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
13
68
1.92
1.33
1.4
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
93
747
1.26
1.32
1.5
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
55
411
1.35
1.32
1.4
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
47
343
1.38
1.31
2.0
2.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
24
2.51
1.30
1.2
1.3
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
6
24
2.51
1.30
13.2
3.8
umol/l
46.7
42.2
—
6
16
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1415
13820
1.15
1.29
4.5
4.2
mmol/l
1.5
1.5
2.29
1302
12762
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
5
18
2.78
1.28
1.0
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
98
796
1.25
1.28
5.7
3.6
kpa
5.2
5.2
0.14
92
754
(3023511) Choriogonadotropin [Units/volume] in Urine
39
277
1.42
1.27
1.4
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
22
138
1.60
1.26
1.1
1.2
u/l
58.2
54.4
0.19
17
95
(3007566) Smooth muscle Ab [Titer] in Serum
49
363
1.36
1.25
1.2
1.2
—
68.0
—
0
25
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
25
2.40
1.24
1.3
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
25
2.40
1.24
1.2
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
8
36
2.23
1.24
2.0
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
97
790
1.24
1.24
5.6
3.6
ph
7.4
7.4
0.07
16
99
(40768446) Kidney Pathology biopsy report
9
45
2.01
1.23
2.4
1.6
—
—
—
0
0
(4268621)
24
155
1.56
1.23
2.2
2.3
—
—
—
0
0
(4211845)
12
63
1.91
1.23
1.7
2.8
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
10
49
2.05
1.22
2.4
2.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
8
37
2.17
1.21
2.9
1.9
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
59
453
1.31
1.20
2.5
3.6
g/l
0.6
0.3
0.59
34
185
(3009871) Measles virus Ab [Titer] in Serum
8
38
2.11
1.18
1.6
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
33
231
1.44
1.18
1.4
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
20
125
1.61
1.17
4.0
3.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
20
2.50
1.15
1.4
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
21
134
1.57
1.14
1.7
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
92
753
1.23
1.14
7.4
7.2
mmol/l
24.3
24.6
0.30
86
704
(4034850)
32
448
0.71
1.14
10.1
8.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
31
217
1.44
1.11
2.3
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
29
201
1.45
1.10
1.8
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
25
168
1.50
1.10
1.1
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
25
168
1.50
1.10
1.0
1.3
nmol/l
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
7
32
2.19
1.08
1.0
1.2
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
95
786
1.22
1.08
9.5
9.2
%
1.6
1.3
0.98
95
781
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
39
287
1.37
1.07
1.4
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
33
236
1.41
1.07
1.5
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
161
1.50
1.07
1.7
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
37
271
1.37
1.05
2.4
2.1
g/l
135.4
129.9
0.71
24
206
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
22
324
0.67
1.04
1.8
1.5
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
9
46
1.96
1.03
1.4
1.2
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
7
34
2.06
1.03
2.6
1.3
%
56.0
26.9
—
7
21
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
75
1.74
1.03
1.1
1.2
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
25
171
1.47
1.02
1.4
1.8
—
1453.3
—
0
6
(44816559) Phosphatidylethanol [Mass/volume] in Blood
36
265
1.37
1.00
1.5
1.3
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
28
197
1.43
1.00
1.1
1.0
u/ml
3.2
2.3
0.18
13
74
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
24
164
1.47
0.99
1.3
1.5
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
24
164
1.47
0.99
1.1
1.0
u/ml
0.1
0.6
—
8
48
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
27
189
1.44
0.99
1.4
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
324
2966
1.11
0.99
4.0
3.9
kg/l
1.0
1.0
0.24
43
439
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
31
223
1.40
0.99
1.1
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
91
758
1.21
0.98
1.3
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
9
49
1.84
0.98
1.2
1.6
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
23
2.18
0.98
9.0
2.6
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
23
2.18
0.98
1.6
1.9
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
21
140
1.51
0.97
4.5
3.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
71
577
1.24
0.97
6.4
3.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
91
761
1.21
0.95
5.5
3.6
mmol/l
1.4
1.8
0.48
72
578
(3015183) Erythrocyte sedimentation rate
14
85
1.65
0.94
1.5
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
36
269
1.35
0.93
1.3
1.3
u/ml
258.9
247.3
0.07
16
161
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
12
70
1.72
0.92
1.2
1.9
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
9
52
1.73
0.92
1.6
1.7
—
—
—
0
0
(3035880) pH of Pleural fluid
9
52
1.73
0.92
1.1
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
24
167
1.44
0.92
1.8
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
30
218
1.38
0.91
1.1
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1362
13343
1.11
0.91
4.1
3.8
mmol/l
1.3
1.3
1.41
1243
12255
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
14
86
1.63
0.91
1.5
1.6
u/l
22.0
6.7
—
8
43
(3023199) Leukocytes [#/volume] in Pleural fluid
18
118
1.53
0.91
1.3
1.3
e6/l
1638.6
1671.4
—
10
76
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
15
94
1.60
0.90
1.4
1.2
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
16
102
1.57
0.90
1.1
1.5
umol/l
10.5
11.7
0.33
16
97
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
38
288
1.33
0.90
1.0
1.1
u/ml
1.0
1.8
0.53
23
127
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
60
484
1.25
0.89
2.2
1.9
ug/l
0.7
1.2
0.95
49
425
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
6
29
2.07
0.89
1.0
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
47
368
1.29
0.89
1.2
1.2
—
494.6
—
0
13
(3014007) Fractional oxyhemoglobin in Arterial blood
93
786
1.19
0.89
9.9
9.3
%
94.3
94.1
0.28
93
781
(1617658) Protocol used for examination of sentinel lymph nodes
9
155
0.58
0.88
1.0
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
30
220
1.37
0.87
1.6
1.5
nmol/l
0.4
0.3
0.28
25
171
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
15
95
1.58
0.87
1.4
1.2
—
—
—
0
0
(44790049)
21
144
1.46
0.87
1.8
1.5
—
—
—
0
0
(44790048)
21
144
1.46
0.87
1.8
1.5
—
—
—
0
0
(44806118)
21
144
1.46
0.87
1.8
1.5
—
—
—
0
0
(44790047)
21
144
1.46
0.87
1.8
1.5
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
29
212
1.37
0.86
1.4
1.4
u/l
31.5
28.8
0.13
24
176
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
63
514
1.23
0.86
2.3
2.1
u/l
935.8
3917.5
1.83
22
222
(1616796) Gas panel - Central venous blood
35
265
1.33
0.84
4.1
3.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
31
1.94
0.84
1.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
31
1.94
0.84
2.2
2.5
umol/l
14.7
17.8
—
6
31
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
8
45
1.78
0.84
2.1
2.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
22
154
1.43
0.83
1.3
1.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
39
301
1.30
0.83
3.5
2.7
mmol/l
24.5
25.2
0.44
33
270
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
40
511
0.78
0.83
1.5
2.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
46
1.74
0.82
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
8
46
1.74
0.82
1.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
33
249
1.33
0.82
1.0
1.1
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
89
756
1.19
0.82
3.1
3.0
g/l
130.6
128.3
0.47
83
732
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
62
509
1.23
0.81
6.7
4.0
mmol/l
24.8
25.0
0.21
57
482
(3034426) Prothrombin time (PT)
8
47
1.71
0.80
1.1
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
25
181
1.39
0.80
1.0
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
302
2790
1.10
0.79
4.4
4.6
ug/l
3.3
2.4
0.45
266
2482
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
44
348
1.27
0.79
1.5
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
121
1058
1.15
0.79
4.6
3.3
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
11
67
1.65
0.75
1.2
1.3
nmol/l
111.2
135.1
0.97
11
67
(3025018) Bordetella pertussis Ab [Titer] in Serum
13
83
1.57
0.75
1.1
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
24
2.09
0.74
1.2
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
54
1.67
0.74
1.1
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
55
1.64
0.73
1.6
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
55
1.64
0.73
1.6
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
35
272
1.29
0.73
5.1
4.0
mmol/l
2.9
2.8
0.18
30
188
(3042111) Morphology [Interpretation] in Bone marrow Narrative
30
228
1.32
0.73
1.4
1.5
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
25
2.00
0.72
1.4
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
12
76
1.58
0.71
1.2
1.2
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
35
273
1.29
0.71
5.1
4.0
kpa
8.5
8.6
0.11
35
268
(3013290) Carbon dioxide [Partial pressure] in Blood
35
273
1.29
0.71
5.1
4.0
kpa
5.4
5.1
1.76
35
268
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
19
134
1.42
0.71
1.1
1.1
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
40
1.75
0.71
1.1
1.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
70
592
1.19
0.70
2.9
3.1
mmol/l
25.6
25.3
0.29
63
568
(3042733) HLA Ab [Presence] in Serum
7
41
1.71
0.70
6.7
5.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
41
1.71
0.70
1.1
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
7
41
1.71
0.70
1.3
1.3
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
20
274
0.73
0.69
4.0
2.9
mmol/l
1.8
1.5
0.66
20
264
(3025468) Yersinia sp identified in Specimen by Organism specific culture
23
169
1.37
0.69
1.6
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
23
169
1.37
0.69
1.6
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
10
61
1.64
0.68
1.1
3.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
42
1.67
0.68
1.1
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
42
1.67
0.68
1.1
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
69
1.60
0.68
1.5
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
23
170
1.36
0.67
1.6
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
23
170
1.36
0.67
1.6
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
17
119
1.43
0.67
1.0
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
28
214
1.31
0.67
1.2
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
43
1.63
0.67
1.1
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
7
43
1.63
0.67
1.1
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
308
2874
1.09
0.66
1.7
1.6
pmol/l
46038159.2
39708154.4
0.07
265
2395
(3002523) Influenza virus A Ag [Presence] in Specimen
32
250
1.29
0.66
1.0
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
12
78
1.54
0.65
1.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
7
44
1.59
0.65
3.3
10.6
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
15
103
1.46
0.65
1.3
1.3
e6/l
33449.3
38343.2
—
7
56
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
239
2209
1.10
0.64
4.0
4.0
%
21.7
21.2
0.17
98
996
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
14
95
1.48
0.64
1.9
1.7
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
29
1.73
0.64
1.0
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
23
172
1.34
0.63
1.6
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
79
1.52
0.62
1.0
1.0
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
19
257
0.74
0.62
4.2
3.0
mmol/l
9.1
7.5
0.67
19
248
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
177
1615
1.11
0.62
2.8
2.8
ug/l
0.6
0.7
1.79
112
993
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
71
1.55
0.62
1.5
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
23
173
1.33
0.62
1.6
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
13
187
0.69
0.61
1.4
1.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
8
51
1.57
0.60
1.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
15
105
1.43
0.60
1.0
1.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
21
158
1.33
0.57
1.8
1.7
%
39.3
60.0
1.49
16
100
(3016650) Hepatitis A virus Ab [Presence] in Serum
30
238
1.27
0.57
1.3
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
8
55
1.46
0.56
2.6
3.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
27
212
1.28
0.55
2.7
2.5
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
6
37
1.62
0.55
1.2
1.6
—
—
—
0
0
(4024509)
8
122
0.65
0.54
1.9
1.5
—
—
—
0
0
(4133840)
6
39
1.54
0.53
1.0
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
39
1.54
0.53
1.2
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
28
224
1.25
0.51
1.2
1.3
mmol/l
65.4
60.2
0.30
23
178
(3007930) Methemoglobin/Hemoglobin.total in Blood
57
491
1.17
0.50
6.1
6.2
%
0.9
0.9
0.17
51
456
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
20
153
1.31
0.50
2.6
1.8
pg
32.0
32.3
0.11
20
153
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
45
1.56
0.49
3.1
2.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
497
5169
0.95
0.48
2.6
2.7
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
21
163
1.29
0.48
2.2
2.1
mg/l
43.2
29.4
—
6
47
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
12
85
1.41
0.47
1.1
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
84
0.59
0.45
2.0
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
84
0.59
0.45
1.0
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
15
112
1.34
0.44
1.7
1.6
%
40.6
34.9
—
10
68
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
31
1.61
0.43
1.4
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
81
901
0.89
0.43
1.5
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
23
284
0.81
0.42
1.6
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
34
403
0.84
0.42
1.3
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
33
1.52
0.41
1.2
1.2
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
15
0.00
0.41
0.0
1.3
—
10.5
—
0
6
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
260.4
—
0
8
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
16
0.00
0.41
0.0
2.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
16
0.00
0.41
0.0
1.2
—
1.9
—
0
16
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
17
0.00
0.40
0.0
3.4
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
17
0.00
0.40
0.0
2.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
17
0.00
0.40
0.0
3.3
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
24
195
1.23
0.40
1.5
2.0
—
3.4
—
0
5
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
34
1.47
0.40
1.2
1.1
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
34
287
1.19
0.40
7.9
3.1
kpa
8.0
8.3
0.44
29
268
(40767503) Oxygen content in Capillary blood by calculation
29
241
1.21
0.40
2.6
2.4
%
17.0
16.4
0.43
17
127
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
48
549
0.87
0.39
3.6
3.5
%
60.3
48.5
2.55
48
540
(3022689) Creatine [Moles/volume] in Urine
5
35
1.43
0.39
1.4
1.6
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
11
80
1.38
0.38
1.4
2.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
36
1.39
0.38
1.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
9
68
1.33
0.37
1.0
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
56
496
1.13
0.37
6.2
6.1
%
1.8
1.6
0.76
49
462
(4306422)
26
217
1.20
0.35
1.2
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
25
208
1.20
0.35
1.3
1.2
—
—
—
0
0
(1002224) Polysomnography panel
66
596
1.11
0.33
1.1
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
61
677
0.90
0.33
3.7
3.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
124
1329
0.93
0.33
1.7
1.7
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
74
1.35
0.32
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
74
1.35
0.32
1.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
12
92
1.31
0.32
1.1
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
13
101
1.29
0.31
1.7
2.4
%
12.4
10.6
0.71
13
101
(21494755) Public health laboratory ask at order entry panel
134
1426
0.93
0.30
1.3
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
115
1074
1.08
0.30
2.3
2.4
ml/min/173m2
67.3
68.8
0.15
47
416
(21494890) Protein electrophoresis panel - 24 hour Urine
16
130
1.23
0.28
2.8
2.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
11
140
0.78
0.28
1.5
2.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
64
1.25
0.27
1.3
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
64
1.25
0.27
1.3
1.6
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
14
113
1.24
0.26
1.6
1.7
mg/l
3.9
3.8
0.02
14
108
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
77
1.30
0.26
1.2
1.5
—
—
—
0
0
(3000012) Reticulocyte production index
9
74
1.22
0.25
1.8
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
18
151
1.19
0.25
1.1
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
13
105
1.24
0.24
2.0
1.5
g/l
1.0
1.0
0.03
13
105
(3012441) Differential panel - Pleural fluid
13
105
1.24
0.24
1.5
1.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
20
170
1.18
0.24
2.3
2.5
u/ml
4.7
27.9
0.50
20
160
(3017817) Protein [Mass] in Urine collected for unspecified duration
13
106
1.23
0.23
2.9
2.4
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
16
134
1.20
0.23
1.9
1.4
e6/l
14290.1
82152.1
0.75
11
95
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
19
162
1.17
0.23
2.4
2.5
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
5
40
1.25
0.22
1.6
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
98
924
1.06
0.22
2.9
2.9
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
12
0.00
0.21
0.0
2.4
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
13
0.00
0.21
0.0
6.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
26
230
1.13
0.20
1.2
1.1
iu/ml
41.3
143.8
—
7
50
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
48
1.25
0.20
1.0
1.0
iu/ml
123.9
180.1
—
6
48
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
48
1.25
0.20
1.0
1.1
—
—
—
0
0
(44813793)
13
108
1.21
0.20
1.2
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
45
413
1.09
0.20
3.0
2.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
26
231
1.13
0.19
1.2
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
21
239
0.88
0.19
1.5
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
139
1332
1.05
0.19
3.3
4.3
ug/l
105.6
23.7
0.49
110
1081
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
6
53
1.13
0.18
4.0
2.3
nmol/l
87.0
140.1
—
6
47
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
42
387
1.09
0.17
1.4
1.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
11
91
1.21
0.17
1.8
1.4
—
1.5
—
0
5
(3017315) Amylase [Enzymatic activity/volume] in Urine
5
68
0.73
0.17
2.0
1.4
u/l
146.6
454.6
—
5
63
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
11
92
1.20
0.16
1.3
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
30
328
0.91
0.15
6.3
4.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
33
303
1.09
0.15
1.3
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
14
160
0.87
0.14
1.3
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
13
113
1.15
0.13
1.0
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
94
1.17
0.13
1.5
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
9
110
0.82
0.13
1.1
1.1
—
—
—
0
0
(4281824)
16
179
0.89
0.12
1.1
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
26
282
0.92
0.12
1.3
1.9
nmol/l
0.8
0.8
0.05
20
233
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
30
323
0.93
0.12
1.8
2.4
ug/min
254.7
132.6
0.21
17
198
(3018405) Lactate [Moles/volume] in Arterial blood
47
445
1.06
0.11
4.7
3.5
mmol/l
1.5
1.4
0.28
47
440
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
17
153
1.11
0.11
1.2
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
38
358
1.06
0.10
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
38
358
1.06
0.10
1.3
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
54
566
0.95
0.10
1.6
1.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
45
1.11
0.09
1.6
1.4
ug/l
6.4
9.1
—
5
45
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
47
1.06
0.09
1.0
1.0
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
5
48
1.04
0.09
2.2
3.4
mg/l
7.0
7.3
—
5
39
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
38
360
1.06
0.09
1.3
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
54
1.11
0.09
2.8
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
55
1.09
0.09
3.8
1.6
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
38
361
1.05
0.08
1.3
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
5
60
0.83
0.08
1.6
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
13
117
1.11
0.08
1.2
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
30
283
1.06
0.08
3.3
3.5
mg/l
28.9
24.8
0.28
17
177
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
65
1.08
0.08
1.6
1.4
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
42
401
1.05
0.08
1.5
1.5
pmol/l
97.3
219.2
1.62
42
392
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
68
1.03
0.07
1.4
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
166
1689
0.98
0.07
4.7
4.4
%
32.5
32.4
0.06
123
1132
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
58
562
1.03
0.06
1.3
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
68
663
1.03
0.05
1.5
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
14
151
0.93
0.05
3.3
2.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
11
100
1.10
0.05
1.5
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
10
110
0.91
0.05
1.0
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
58
565
1.03
0.04
1.6
1.8
mg/l
3.7
4.3
0.16
37
401
(3014051) Protein [Presence] in Urine by Test strip
33
318
1.04
0.04
1.6
2.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
23
241
0.95
0.04
1.8
1.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
121
1.07
0.03
1.3
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
43
441
0.97
0.03
1.3
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
14
132
1.06
0.02
1.9
1.6
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
15
142
1.06
0.02
1.1
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
23
222
1.04
0.02
1.0
1.1
—
—
—
0
0
(4146454)
15
143
1.05
0.01
2.8
2.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
163
1638
0.99
0.01
8.5
6.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
30
294
1.02
0.00
1.3
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
12
115
1.04
0.00
1.3
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
18
175
1.03
0.00
1.1
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
19
194
0.98
0.00
1.6
1.3
mmol/l
7.6
7.4
0.05
14
137
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
46
464
0.99
0.00
2.2
3.4
u/ml
258.3
2962.7
0.68
37
402
(3020891) Body temperature
49
494
0.99
0.00
5.4
4.3
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
10
98
1.02
0.00
1.7
1.5
—
65.4
—
0
10
(3045424) Erythrocytes [Presence] in Urine
23
227
1.01
0.00
1.3
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
30
297
1.01
0.00
1.3
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
61
607
1.01
0.00
1.5
1.8
—
—
—
0
0
(40758358) Immune stain study
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
8
0.00
0.00
0.0
1.1
—
8.0
—
0
8
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
5
57
0.88
0.00
1.2
1.6
—
1224630.0
—
0
5
(3005082) Progesterone [Moles/volume] in Serum or Plasma
6
69
0.87
0.00
1.2
1.4
nmol/l
31.3
32.7
—
6
56
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
335.0
—
0
7
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
13.8
—
0
9
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
54
0.93
0.00
3.0
2.3
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
0.2
—
0
5
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
5
0.00
0.00
0.0
6.8
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
93
0.97
0.00
1.0
1.1
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(4038314)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
66
0.91
0.00
1.8
2.8
—
—
—
0
0
(3013762) Body weight Measured
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
89
0.90
0.00
1.1
1.2
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H7_ORBIT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_ORBIT | 1.329 [1.18, 1.49] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.125 |
During the follow-up period (1.1.1998 — 31.12.2019), 737 out of 5877 females with H7_ORBIT died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_ORBIT | 1.431 [1.24, 1.65] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.018 |
During the follow-up period (1.1.1998 — 31.12.2019), 575 out of 3310 males with H7_ORBIT died.
Mortality risk
Mortality risk for people of age
years, who have H7_ORBIT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.149% | 0.331% |
| 5 | 0.859% | 1.848% |
| 10 | 1.888% | 4.304% |
| 15 | 3.475% | 8.147% |
| 20 | 6.072% | 13.883% |
Relationships between endpoints
↥Index endpoint: H7_ORBIT – Disorders of orbit
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data